Potential biomarker to predict risk of recurrence after nephrectomy for locally advanced kidney cancer
Currently, the search for a reliable biomarker to identify those [...]
Currently, the search for a reliable biomarker to identify those [...]
Interim results from a phase 3 clinical trial called KEYNOTE-564 [...]
This study looked at the use of pegilodecakin alone or [...]
Following suspensions by some countries of the COVID-19 Oxford AstraZeneca [...]
In an attempt to reduce treatment backlogs and hospital visits, [...]
The European Commission has approved the use of the nivolumab [...]
Cancer Research UK conducted a survey with cancer patients from [...]